Vitamin K-2 100 mcg

Vitamin K2 as MK-4 and alfalfa powder provide foundational support for skeletal and cardiovascular pathways. This combination contributes to long-term health by aiding in the regulation of calcium metabolism.

Providing a consistent 100 mcg dose of MK-4 appears well-aligned with maintaining basic vitamin status. While this form is shorter-acting than other subtypes, it meaningfully contributes to systemic resilience for daily wellness.

Vitamin K2 is provided here in the MK-4 form, which supports the activation of bone-building proteins like osteocalcin. However, the 100 mcg dose is quite low for this specific isomer, as clinical trials typically utilize much higher amounts for meaningful skeletal benefits.

Alfalfa powder is included as a botanical base, but it does not contribute significantly to bone mineral density at the levels provided. The lack of MK-7 or other synergistic vitamins like D3 makes this a less comprehensive option for bone support.

Vitamin K2 as MK-4 supports calcium metabolism and contributes to arterial health by activating matrix Gla-protein. This mechanism is relevant for maintaining the structural integrity of blood vessels.

MK-4 has a shorter biological half-life than MK-7, requiring higher or more frequent dosing for similar cardiovascular outcomes. The current 100 mcg dose is low for this specific subtype, which may limit its overall effectiveness for arterial maintenance.

NOW Vitamin K-2 (100 mcg) utilizes the MK-4 form of Menaquinone, which is effective for skeletal health but possesses a shorter biological half-life than MK-7. Adding Alfalfa powder provides a natural source of trace nutrients to support the active ingredient.

While functional, this formula is less optimized for cardiovascular anti-aging goals than its MK-7 counterparts. It provides a basic and affordable entry point for structural support but lacks multi-pathway coverage.

This supplement contains 100mcg of Vitamin K2 in the MK-4 form to support arterial health. While MK-4 is a bioactive form of Vitamin K2, it has a much shorter half-life in the body compared to the MK-7 subtype.

Providing MK-4 may contribute to managing calcium distribution and protecting blood vessels. However, its lower biological longevity and the dry capsule format may limit its clinical effectiveness for long-term cardiovascular support.